COVID-19 mortality among selective serotonin reuptake inhibitor users - Results from a nationwide cohort
Description
CONCLUSION: We found significantly higher mortality when comparing SSRI-users to non-SSRI-users within60 days after a positive SARS-CoV-2 PCR test. Even when considering possible residual confounding positive effect of SSRI-intake seems highly
